JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis. [electronic resource]
Producer: 20141007Description: 1736-8 p. digitalISSN:- 1476-5551
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.